Thompson M E, Valentine D L, Strada S J, Wagner J A, Scammell J G
Department of Pharmacology, University of South Alabama College of Medicine, Mobile 36688.
Mol Pharmacol. 1994 Nov;46(5):880-9.
When PC-12 cells were treated with 10 microM forskolin, the expression of two members of the granin family, secretogranin II (SgII) and chromogranin B (CgB), were differentially regulated. SgII mRNA levels declined progressively after forskolin treatment to reach a level of 22 +/- 1% of control after 48 hr, whereas CgB mRNA levels increased more rapidly, reaching a maximum of 3-fold above control after 24 hr. The dependence of these changes on an increase in cellular cAMP levels, activation of cAMP-dependent protein kinase (PKA), protein synthesis, and changes in the rate of transcription was investigated. The effects of forskolin on SgII and CgB mRNAs were reproduced by 1 mM 8-bromo-cAMP but not by 10 microM 1,9-dideoxyforskolin, an inactive analog of forskolin. The actions of forskolin on SgII and CgB mRNAs were blocked by treatment with 60 microM H-89, a selective PKA inhibitor, and were blunted in PKA-deficient PC-12 cell clones. To examine whether forskolin action was dependent on ongoing protein synthesis, PC-12 cells were treated with 1 microgram/ml cycloheximide before the addition of forskolin. The reduction in SgII mRNA levels by forskolin was not evident in PC-12 cells treated with cycloheximide. Rather, in the presence of cycloheximide, forskolin stimulated SgII mRNA levels 3.6 +/- 0.7-fold above control. The induction of CgB mRNA by forskolin was not affected by cycloheximide treatment. The superinduction of SgII mRNA by cycloheximide and forskolin was related to the extent of protein synthesis inhibition, was observed in cells treated with forskolin and other protein synthesis inhibitors, and was blunted in PKA-deficient PC-12 cells, suggesting that this effect was dependent on inhibition of protein synthesis and activation of PKA. To determine whether changes in SgII and CgB mRNA levels resulted from changes in the rate of transcription, nuclear run-on assays were performed in nuclei isolated from PC-12 cells that had been treated for 2 hr with cycloheximide, forskolin, or the two combined. Transcription of the SgII gene was not significantly affected by treatment with either forskolin or cycloheximide alone but was increased 12.9 +/- 1.0-fold above control in nuclei from cells treated with cycloheximide and forskolin together. Forskolin caused a 3.8 +/- 0.8-fold induction of CgB transcription.(ABSTRACT TRUNCATED AT 400 WORDS)
用10微摩尔的福斯高林处理PC-12细胞时,嗜铬粒蛋白家族的两个成员,即分泌粒蛋白II(SgII)和嗜铬粒蛋白B(CgB)的表达受到不同调节。福斯高林处理后,SgII mRNA水平逐渐下降,48小时后降至对照水平的22±1%,而CgB mRNA水平升高更快,24小时后达到比对照高3倍的最大值。研究了这些变化对细胞内cAMP水平升高、cAMP依赖性蛋白激酶(PKA)激活、蛋白质合成以及转录速率变化的依赖性。1毫摩尔的8-溴-cAMP可重现福斯高林对SgII和CgB mRNA的影响,但10微摩尔的1,9-二脱氧福斯高林(福斯高林的无活性类似物)则不能。用60微摩尔的H-89(一种选择性PKA抑制剂)处理可阻断福斯高林对SgII和CgB mRNA的作用,且在缺乏PKA的PC-12细胞克隆中作用减弱。为了检测福斯高林的作用是否依赖于正在进行的蛋白质合成,在添加福斯高林之前先用1微克/毫升的放线菌酮处理PC-12细胞。在经放线菌酮处理的PC-12细胞中,福斯高林降低SgII mRNA水平的作用不明显。相反,在放线菌酮存在的情况下,福斯高林刺激SgII mRNA水平比对照高3.6±0.7倍。放线菌酮处理不影响福斯高林对CgB mRNA的诱导。放线菌酮和福斯高林对SgII mRNA的超诱导与蛋白质合成抑制程度有关,在用福斯高林和其他蛋白质合成抑制剂处理的细胞中也观察到这种现象,且在缺乏PKA的PC-12细胞中减弱,这表明这种效应依赖于蛋白质合成的抑制和PKA的激活。为了确定SgII和CgB mRNA水平的变化是否由转录速率的变化引起,对从用放线菌酮、福斯高林或两者联合处理2小时的PC-12细胞中分离出的细胞核进行了核转录分析。单独用福斯高林或放线菌酮处理对SgII基因的转录没有显著影响,但在用放线菌酮和福斯高林共同处理的细胞的细胞核中,转录比对照增加了12.9±1.0倍。福斯高林使CgB转录增加3.8±0.8倍。(摘要截短至400字)